Answers are grounded in this paper and cite their sources.
HNC patients with nasopharyngeal or oropharyngeal tumors, and those who receive cumulative radiation doses > 5000 cGy or concomitant chemotherapy, are more likely to develop OM. Patients with OM are at a higher risk of unplanned breaks in radiation therapy and hospitalization.
No takes yet. Share an insight, caveat, or question.
Vera‐Llonch et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: